Can-Fite BioPharma Ltd. SEC filings CANF
Can-Fite BioPharma Ltd. has 865 filings in SEC EDGAR's recent list, going back to Dec 1, 2011. Its latest annual report, Form 20-F, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 9, 2026 | — |
| EFFECT | Filing | Oct 9, 2026 | — |
| EFFECT | Filing | Sep 11, 2026 | — |
| EFFECT | Filing | Sep 11, 2026 | — |
| D | Filing | Sep 10, 2026 | — |
| EFFECT | Filing | Apr 3, 2026 | — |
| CORRESP | Letter to the SEC | Apr 1, 2026 | — |
| EFFECT | Filing | Mar 31, 2026 | — |
| EFFECT | Filing | Mar 31, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2026 | — |
| EFFECT | Filing | Sep 11, 2025 | — |
| EFFECT | Filing | Sep 11, 2025 | — |
| EFFECT | Filing | Jul 28, 2025 | — |
| CORRESP | Letter to the SEC | Jul 24, 2025 | — |
| CORRESP | Letter to the SEC | Jul 24, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 22, 2025 | — |
| CORRESP | Letter to the SEC | Jul 17, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2025 | — |
| DRS | Filing | Jul 9, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2025 | — |
| EFFECT | Filing | Apr 17, 2025 | — |
| EFFECT | Filing | Sep 6, 2024 | — |
| CORRESP | Letter to the SEC | Sep 6, 2024 | — |
| EFFECT | Filing | Sep 5, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2024 | — |
| EFFECT | Filing | Apr 9, 2024 | — |
| EFFECT | Filing | Jan 5, 2024 | — |
| CORRESP | Letter to the SEC | Jan 3, 2024 | — |
| EFFECT | Filing | Sep 12, 2023 | — |
| CORRESP | Letter to the SEC | Sep 11, 2023 | — |
| EFFECT | Filing | Sep 8, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 8, 2023 | — |
| EFFECT | Filing | Apr 24, 2023 | — |
| EFFECT | Filing | Feb 10, 2023 | — |
| CORRESP | Letter to the SEC | Feb 8, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2023 | — |
| EFFECT | Filing | Sep 1, 2022 | — |
| EFFECT | Filing | Mar 30, 2022 | — |
| EFFECT | Filing | Jan 14, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2022 | — |
| CORRESP | Letter to the SEC | Jan 13, 2022 | — |
| D | Filing | Dec 30, 2021 | — |
| EFFECT | Filing | Sep 1, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 1, 2021 | — |
| CORRESP | Letter to the SEC | Sep 1, 2021 | — |
| EFFECT | Filing | Aug 31, 2021 | — |
| D | Filing | Aug 26, 2021 | — |
| EFFECT | Filing | Apr 8, 2021 | — |
| EFFECT | Filing | Oct 9, 2020 | — |
| CORRESP | Letter to the SEC | Oct 7, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 2, 2020 | — |
| EFFECT | Filing | Sep 4, 2020 | — |
| EFFECT | Filing | Jul 24, 2020 | — |
| CORRESP | Letter to the SEC | Jul 22, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2020 | — |
| D | Filing | Jul 17, 2020 | — |
| D | Filing | Jun 19, 2020 | — |
| EFFECT | Filing | Apr 7, 2020 | — |
| EFFECT | Filing | Apr 7, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2020 | — |
| CORRESP | Letter to the SEC | Apr 6, 2020 | — |
| CORRESP | Letter to the SEC | Apr 6, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 2, 2020 | — |
| EFFECT | Filing | Feb 10, 2020 | — |
| CORRESP | Letter to the SEC | Feb 7, 2020 | — |
| CORRESP | Letter to the SEC | Feb 7, 2020 | — |
| CORRESP | Letter to the SEC | Feb 7, 2020 | — |
| CORRESP | Letter to the SEC | Feb 4, 2020 | — |
| CORRESP | Letter to the SEC | Feb 4, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2020 | — |
| D | Filing | Jan 24, 2020 | — |
| EFFECT | Filing | Oct 18, 2019 | — |
| CORRESP | Letter to the SEC | Oct 18, 2019 | — |
| AW | Withdrawal of amendment to a registration statement | Jul 12, 2019 | — |
| D | Filing | May 31, 2019 | — |
| UPLOAD | Letter from the SEC | May 10, 2019 | — |
| D | Filing | Apr 11, 2019 | — |
| EFFECT | Filing | Mar 22, 2019 | — |
| CORRESP | Letter to the SEC | Mar 20, 2019 | — |
| D | Filing | Jan 24, 2019 | — |
| EFFECT | Filing | Sep 13, 2018 | — |
| CORRESP | Letter to the SEC | Sep 12, 2018 | — |
| EFFECT | Filing | Sep 10, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2018 | — |
| EFFECT | Filing | Apr 4, 2018 | — |
| D | Filing | Mar 22, 2018 | — |
| EFFECT | Filing | Oct 11, 2017 | — |
| CORRESP | Letter to the SEC | Oct 10, 2017 | — |
| CORRESP | Letter to the SEC | Oct 4, 2017 | — |
| CORRESP | Letter to the SEC | Oct 2, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 2, 2017 | — |
| EFFECT | Filing | Jun 13, 2017 | — |
| CORRESP | Letter to the SEC | Jun 12, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 5, 2017 | — |
| CT ORDER | Filing | May 4, 2017 | — |
| D | Filing | Jan 25, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2016 | — |
| EFFECT | Filing | Jan 29, 2016 | — |
| CORRESP | Letter to the SEC | Jan 29, 2016 | — |
| D | Filing | Oct 28, 2015 | — |
| D | Filing | Oct 2, 2015 | — |
| EFFECT | Filing | Jun 23, 2015 | — |
| CORRESP | Letter to the SEC | Jun 22, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2015 | — |
| CT ORDER | Filing | May 26, 2015 | — |
| D | Filing | Dec 17, 2014 | — |
| EFFECT | Filing | Oct 21, 2014 | — |
| EFFECT | Filing | Sep 29, 2014 | — |
| EFFECT | Filing | Apr 24, 2014 | — |
| D | Filing | Mar 24, 2014 | — |
| CERTNYS | Auto-generated paper document | Nov 18, 2013 | — |
| 8-A12B | Form 8-a12b | Nov 15, 2013 | — |
| 20FR12G/A | Form 20fr12g/a | Sep 10, 2013 | — |
| CORRESP | Letter to the SEC | Sep 9, 2013 | — |
| 20FR12G | Filing | Sep 9, 2013 | — |
| DRS/A | Filing | Aug 26, 2013 | — |
| DRS/A | Filing | Jul 1, 2013 | — |
| DRSLTR | Filing | Jul 1, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2013 | — |
| DRSLTR | Filing | Jun 14, 2013 | — |
| DRS/A | Filing | Jun 14, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2013 | — |
| DRSLTR | Filing | May 10, 2013 | — |
| DRS/A | Filing | May 10, 2013 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2013 | — |
| DRS | Filing | Apr 15, 2013 | — |
| EFFECT | Filing | Sep 19, 2012 | — |
Showing 127 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CANF (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Ramat Gan, Israel
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1536196
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.